Selecting the most appropriate commercialisation strategy is key to extracting maximum value from your R&D Online publication date: Fri, 04-Feb-2005
by D. Walwyn
International Journal of Technology Transfer and Commercialisation (IJTTC), Vol. 4, No. 2, 2005
Abstract: Business organisations are presented with many options in the commercialisation of the outcome of a research and development project, including licensing, in-house product launch, direct sale of a technology packaging or spinning off a new venture with other investors. In this article, a simple framework is introduced that can be used to select a suitable commercialisation strategy according to two parameters of the innovation, namely its strategic fit and the estimated value or risk-adjusted net present value of the opportunity. The use of this framework is illustrated with two examples, the first involving the development of a new product that is a significant innovation on an existing process or product line, and the second being the commercialisation of a biopharmaceutical. In both cases, the option of licensing is explored, and a further technique for identifying the most suitable point for the license event is presented.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technology Transfer and Commercialisation (IJTTC):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com